These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 32104955

  • 21. Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer.
    Kawaguchi K, Miyake K, Han Q, Li S, Tan Y, Igarashi K, Lwin TM, Higuchi T, Kiyuna T, Miyake M, Oshiro H, Bouvet M, Unno M, Hoffman RM.
    Cell Cycle; 2018; 17(7):868-873. PubMed ID: 29623758
    [Abstract] [Full Text] [Related]

  • 22. S-Adenosylmethionine synergistically enhances the antitumor effect of gemcitabine against pancreatic cancer through JAK2/STAT3 pathway.
    Liu Y, Bi T, Liu L, Gao Q, Shen G, Qin L.
    Naunyn Schmiedebergs Arch Pharmacol; 2019 May; 392(5):615-622. PubMed ID: 30683944
    [Abstract] [Full Text] [Related]

  • 23. Ginsenoside Rg3 inhibits cell growth, migration and invasion in Caco-2 cells by downregulation of lncRNA CCAT1.
    Li J, Qi Y.
    Exp Mol Pathol; 2019 Feb; 106():131-138. PubMed ID: 30633886
    [Abstract] [Full Text] [Related]

  • 24. Low‑intensity low‑frequency ultrasound enhances the chemosensitivity of gemcitabine‑resistant ASPC‑1 cells via PI3K/AKT/NF‑κB pathway‑mediated ABC transporters.
    Qiu F, Chen J, Cao J, Diao F, Huang P.
    Oncol Rep; 2020 Sep; 44(3):1158-1168. PubMed ID: 32705228
    [Abstract] [Full Text] [Related]

  • 25. Ginsenoside Rg3 inhibits colorectal tumor growth via down-regulation of C/EBPβ/NF-κB signaling.
    Yang X, Zou J, Cai H, Huang X, Yang X, Guo D, Cao Y.
    Biomed Pharmacother; 2017 Dec; 96():1240-1245. PubMed ID: 29169725
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Luteolin and Gemcitabine Protect Against Pancreatic Cancer in an Orthotopic Mouse Model.
    Johnson JL, Dia VP, Wallig M, Gonzalez de Mejia E.
    Pancreas; 2015 Jan; 44(1):144-51. PubMed ID: 25237909
    [Abstract] [Full Text] [Related]

  • 28. MGMT expression affects the gemcitabine resistance of pancreatic cancer cells.
    Shi Y, Wang Y, Qian J, Yan X, Han Y, Yao N, Ma J.
    Life Sci; 2020 Oct 15; 259():118148. PubMed ID: 32721465
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Hexokinase 2 dimerization and interaction with voltage-dependent anion channel promoted resistance to cell apoptosis induced by gemcitabine in pancreatic cancer.
    Fan K, Fan Z, Cheng H, Huang Q, Yang C, Jin K, Luo G, Yu X, Liu C.
    Cancer Med; 2019 Oct 15; 8(13):5903-5915. PubMed ID: 31426130
    [Abstract] [Full Text] [Related]

  • 31. Ginsenoside Rg3 regulates DNA damage in non-small cell lung cancer cells by activating VRK1/P53BP1 pathway.
    Liu T, Zuo L, Guo D, Chai X, Xu J, Cui Z, Wang Z, Hou C.
    Biomed Pharmacother; 2019 Dec 15; 120():109483. PubMed ID: 31629252
    [Abstract] [Full Text] [Related]

  • 32. Antitumor activity and combined inhibitory effect of ceritinib with gemcitabine in pancreatic cancer.
    Jamshed MB, Munir F, Shahid N, Sadiq U, Muhammad SA, Ghanem NB, Zhong H, Li X, Zhang Q.
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan 01; 318(1):G109-G119. PubMed ID: 31736340
    [Abstract] [Full Text] [Related]

  • 33. BRD4 promotes pancreatic ductal adenocarcinoma cell proliferation and enhances gemcitabine resistance.
    Wang YH, Sui YN, Yan K, Wang LS, Wang F, Zhou JH.
    Oncol Rep; 2015 Apr 01; 33(4):1699-706. PubMed ID: 25647019
    [Abstract] [Full Text] [Related]

  • 34. Qingyihuaji formula reverses gemcitabine resistant human pancreatic cancer through regulate lncRNA AB209630/miR-373/EphB2-NANOG signals.
    Chen P, Wang M, Wang C.
    Biosci Rep; 2019 Jun 28; 39(6):. PubMed ID: 31147453
    [Abstract] [Full Text] [Related]

  • 35. The enhancement of Tetrandrine to gemcitabine-resistant PANC-1 cytochemical sensitivity involves the promotion of PI3K/Akt/mTOR-mediated apoptosis and AMPK-regulated autophagy.
    Song J, Xu J, Guo J, Shang Y, Wang J, Wang T.
    Acta Histochem; 2021 Sep 28; 123(6):151769. PubMed ID: 34416437
    [Abstract] [Full Text] [Related]

  • 36. Targeted nuclear factor-kappaB suppression enhances gemcitabine response in human pancreatic tumor cell line murine xenografts.
    Waters JA, Matos J, Yip-Schneider M, Aguilar-Saavedra JR, Crean CD, Beane JD, Dumas RP, Suvannasankha A, Schmidt CM.
    Surgery; 2015 Oct 28; 158(4):881-8; discussion 888-9. PubMed ID: 26209568
    [Abstract] [Full Text] [Related]

  • 37. ARID3A enhances chemoresistance of pancreatic cancer via inhibiting PTEN-induced ferroptosis.
    Mao X, Xu J, Xiao M, Liang C, Hua J, Liu J, Wang W, Yu X, Meng Q, Shi S.
    Redox Biol; 2024 Jul 28; 73():103200. PubMed ID: 38781729
    [Abstract] [Full Text] [Related]

  • 38. [Role of nuclear factor-kappaB on emodin-induced sensitization of pancreatic cancer to gemcitabine].
    Liu A, Hu YS, Wang ZH, Tang LL, Ke PY, Lin SZ.
    Yao Xue Xue Bao; 2011 Feb 28; 46(2):146-52. PubMed ID: 21542284
    [Abstract] [Full Text] [Related]

  • 39. Emodin reverses gemcitabine resistance in pancreatic cancer cells via the mitochondrial apoptosis pathway in vitro.
    Liu DL, Bu H, Li H, Chen H, Guo HC, Wang ZH, Tong HF, Ni ZL, Liu HB, Lin SZ.
    Int J Oncol; 2012 Apr 28; 40(4):1049-57. PubMed ID: 22159556
    [Abstract] [Full Text] [Related]

  • 40. Enhancement of the CXCL12/CXCR4 axis due to acquisition of gemcitabine resistance in pancreatic cancer: effect of CXCR4 antagonists.
    Morimoto M, Matsuo Y, Koide S, Tsuboi K, Shamoto T, Sato T, Saito K, Takahashi H, Takeyama H.
    BMC Cancer; 2016 May 12; 16():305. PubMed ID: 27175473
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.